Although Zhu et al. reported an association between a high KPNA2 RNA expression level and shorter OS in patients with relapsed/refractory MM who were treated with IMIDs10, we did not identify an association between the expression of the KPNA2 protein and clinical/prognostic variables. Here, KPNA2 is linked to Miyoshi myopathy.